Experiments in breast cancer indicated that the expression of ?133p53 is up-regulated in p53-independent manner with p68 siRNA knockdown, and could inhibit the ability of p68 to coactivate p53-dependent induction to the cell cycle inhibitor p21 [67]. Here, TP53 is linked to breast cancer.